Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Angelina Tjokrowidjaja"'
Publikováno v:
Internal Medicine Journal. 53:131-135
Autor:
Jonathan A. Ledermann, Rebecca Asher, Michael Friedlander, Ilan Bruchim, Sarah J. Lord, Eric Pujade-Lauraine, Ronnie Shapira-Frommer, Clare L. Scott, Ursula A. Matulonis, Amit M. Oza, Philipp Harter, Charlie Gourley, Tomasz Huzarski, Val Gebski, Angelina Tjokrowidjaja, Chee Khoon Lee, Ignace Vergote, Manuel Rodrigues, Werner Meier, Tsveta Milenkova
Publikováno v:
European Journal of Cancer. 154:190-200
Background The impact of maintenance therapy with PARP inhibitors (PARPi) on progression-free survival (PFS) in patients with BRCA mutations and platinum-sensitive recurrent ovarian cancer (PSROC) varies widely. Individual prognostic factors do not r
Publikováno v:
Asia-Pacific Journal of Clinical Oncology. 18
AIM The American Joint Committee on Cancer (AJCC) melanoma staging system eighth edition (AJCC-8) was recently released to provide accurate staging reflecting advances in the treatment of melanoma. Using population registry data, this study independe
Autor:
Rosalind Glasspool, Robert L. Coleman, Chee Khoon Lee, Ralph Bloomfield, Ping Wang, Jonathan A. Ledermann, Ursula A. Matulonis, Sandra Goble, Clare L. Scott, Michael Friedlander, Eric Pujade-Lauraine, Mansoor Raza Mirza, Angelina Tjokrowidjaja
Publikováno v:
CancerReferences. 127(14)
BACKGROUND: The authors performed a meta‐analysis to better quantify the benefit of maintenance poly(ADP‐ribose) polymerase inhibitor (PARPi) therapy to inform practice in platinum‐sensitive, recurrent, high‐grade ovarian cancer for patient s
Autor:
Angelina Tjokrowidjaja, Ignace Vergote, Se Ik Kim, Gabe S. Sonke, Richard T. Penson, Michael Friedlander, Amit M. Oza, Keiichi Fujiwara, Chee Khoon Lee, Eric Pujade-Lauraine, Tjoung Won Park-Simon, Val Gebski, Jacob Korach, Jae Weon Kim, Jung Yun Lee, Jonathan A. Ledermann, Carmela Pisano, Laurence Gladieff, Sarah J. Lord, Luis Manso, Rebecca Asher, Tomasz Huzarski, Nicoletta Colombo
Background Limited evidence exists to support CA-125 as a valid surrogate biomarker for progression in patients with ovarian cancer on maintenance PARP inhibitor (PARPi) therapy. We aimed to assess the concordance between CA-125 and Response Evaluati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fce0ebc682f22d2e3ea44062a7a1a93e
http://hdl.handle.net/10281/291288
http://hdl.handle.net/10281/291288
Autor:
Robert J. Motzer, David Goldstein, H. Malcolm Hudson, Stephen Clarke, Val Gebski, Sarah J. Lord, Paul de Souza, Chee Khoon Lee, Angelina Tjokrowidjaja
Publikováno v:
Acta Oncol
BACKGROUND: An elevated neutrophil-lymphocyte ratio (NLR) is associated with poor prognosis in advanced renal cell carcinoma (RCC). We examined whether the addition of NLR improves the risk reclassification of advanced RCC using current prognostic to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eb2b4a0efd26c78d7e376c6096186a5d
https://europepmc.org/articles/PMC7577380/
https://europepmc.org/articles/PMC7577380/
Let's talk about cytotoxic chemotherapy dosing: unravelling adjustments and off-protocol prescribing
Publikováno v:
The Medical journal of Australia. 210(2)
Publikováno v:
Internal Medicine Journal. 44:764-770
Background There is limited information on the risk of metastatic breast cancer (MBC) to inform younger women, particularly those under 40 years. Aims We conducted a retrospective analysis of a population-based cohort study to describe the risk, site
Publikováno v:
Annals of Oncology. 30:v540
Background Changes to the AJCC melanoma staging system eighth edition (AJCC-8) should be independently validated to assess its prognostic performance compared with the seventh edition (AJCC-7) in accurately staging melanoma. Methods We used the SEER-
Autor:
Doah Cho, Rahuram Sivasubramaniam, Tina Baillie, Chee Khoon Lee, Angelina Tjokrowidjaja, John Moses
Publikováno v:
Internal Medicine Journal. 47:1215-1216